AstraZeneca’s Tagrisso slashes death risk in certain post-surgery lung cancer patients – Reuters.com

by

  1. AstraZeneca’s Tagrisso slashes death risk in certain post-surgery lung cancer patients Reuters.com
  2. Lung cancer pill cuts risk of death by half, says ‘thrilling’ study The Guardian
  3. Stopping treatment at two years does not seem to compromise overall survival in patients with advanced lung cancer News-Medical.Net
  4. Game-Changer: Tagrisso May Reduce Risk of Death by Half in Some Early-Stage Lung Cancer Patients, ‘Compelling’ New Data Shows SurvivorNet
  5. ‘Extraordinary’ survival data for lung cancer patients is seen as boost for AstraZeneca drug STAT
  6. View Full Coverage on Google News

Read original article here

Leave a Comment